Redox‐Driven Spatiotemporal Passivation for Efficient and Durable Perovskite Solar Cells

Engineering notes

Engineering notes will be added by the Power for Solar editorial team.

Chinese explanation / 中文解读

中文解读待补充：本站会优先为光伏效率、钙钛矿太阳能电池、储能技术、太阳能热利用、BIPV、并网技术等高价值论文补充中文说明。

Original abstract

ABSTRACT Additives and passivators are commonly used to regulate crystallization and suppress defects in halide perovskites. However, existing additives or passivation agents struggle to concurrently achieve effective defect passivation and efficient charge transport, and their passivation effects often fail to endure throughout device fabrication and operation. Here, we systematically screened a series of redox‐active, bifunctional passivation molecules with various functional motifs, namely sildenafil (SDNF), avanafil (AVNF), and dabrafenib (DRFN), to achieve spatial defect passivation and temporal redox healing in perovskite films. Spatially, the sulfonyl (‐SO 2 ‐) group and heterocyclic nitrogen of DRFN coordinate with perovskites at dual sites, enabling parallel binding to multiple Pb 2+ centers. Temporally, its sulfonyl group exhibits moderate electron‐withdrawing capability, facilitating redox‐mediated defect healing by reducing metallic Pb 0 species. These combined effects yield peak power conversion efficiencies of 25.28% in the n‐i‐p configuration and 26.62% in the p‐i‐n configuration, along with exceptional thermal and operational stability. The unencapsulated device efficiency shows almost no degradation after 1200 h under continuous maximum power point tracking.

Links and sources

Comments